Global pharmaceutical company Merck (NYSE:MRK) reported Q1 CY2025 results , but sales fell by 1.6% year on year to $15.53 ...

Argus Research analyst John Staszak upgraded the rating for Wayfair Inc. W from Hold to Buy and announced a $40 price target.

Digital transformation in pharma has accelerated faster than perhaps once anticipated, as a result of the COVID-19 pandemic. It’s a topic that is causing debate and business pressure ...

Barrington Research raised DENTSPLY SIRONA Inc. XRAY price target from $20 to $21. Barrington Research analyst Michael ...